Stefan Schmidbauer

Person

Lahntal, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Methods of administering inhibitory anti-factor XII/XIIa monoclonal...
- Patent number 11,345,759
- Issue date May 31, 2022
- CSL Behring GmbH
- Con Panousis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of administering inhibitory anti-factor XII/XIIA monoclonal...
- Patent number 10,513,560
- Issue date Dec 24, 2019
- CSL Behring GmbH
- Con Panousis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Nucleic acids encoding inhibitory anti-factor XII/XIIa monoclonal a...
- Patent number 9,856,325
- Issue date Jan 2, 2018
- CSL Behring GmbH
- Con Panousis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of administering inhibitory anti-factor XII/XIIA monoclonal...
- Patent number 9,856,326
- Issue date Jan 2, 2018
- CSL Behring GmbH
- Con Panousis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitory anti-factor XII/XIIA monoclonal antibodies and their uses
- Patent number 9,518,127
- Issue date Dec 13, 2016
- CSL Behring GmbH
- Con Panousis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutic application of Kazal-type serine protease inhibitors
- Patent number 8,283,319
- Issue date Oct 9, 2012
- CSL Behring GmbH
- Stefan Schulte
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for purifying enzymes from clostridium histolyticum using mu...
- Patent number 7,083,964
- Issue date Aug 1, 2006
- Nordmark Arzneimittel GmbH & Co. KG
- Manfred Kurfürst
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
METHODS OF ADMINISTERING INHIBITORY ANTI-FACTOR XII/XIIA MONOCLONAL...
- Publication number 20200062863
- Publication date Feb 27, 2020
- CSL BEHRING GMBH
- Con Panousis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMPROVED FACTOR VIII PREPARATIONS SUITABLE FOR THERAPEUTIC USE AND...
- Publication number 20170209546
- Publication date Jul 27, 2017
- CSL BEHRING GMBH
- Stefan SCHMIDBAUER
- G01 - MEASURING TESTING
Information Patent Application
INHIBITORY ANTI-FACTOR XII/XIIA MONOCLONAL ANTIBODIES AND THEIR USES
- Publication number 20170137536
- Publication date May 18, 2017
- CSL BEHRING GMBH
- Con Panousis
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
INHIBITORY ANTI-FACTOR XII/XIIA MONOCLONAL ANTIBODIES AND THEIR USES
- Publication number 20170121423
- Publication date May 4, 2017
- CSL BEHRING GMBH
- Con Panousis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORY ANTI-FACTOR XII/XIIA MONOCLONAL ANTIBODIES AND THEIR USES
- Publication number 20140199361
- Publication date Jul 17, 2014
- Con Panousis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC APPLICATION OF KAZAL-TYPE SERINE PROTEASE INHIBITORS
- Publication number 20100279923
- Publication date Nov 4, 2010
- Stefan Schulte
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method for purifying an enzyme, a purified enzyme produced thereby,...
- Publication number 20040137596
- Publication date Jul 15, 2004
- Manfred Kurfürst
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Stefan Schmidbauer

Person

Patents Grantslast 30 patents

Methods of administering inhibitory anti-factor XII/XIIa monoclonal...

Methods of administering inhibitory anti-factor XII/XIIA monoclonal...

Nucleic acids encoding inhibitory anti-factor XII/XIIa monoclonal a...

Methods of administering inhibitory anti-factor XII/XIIA monoclonal...

Inhibitory anti-factor XII/XIIA monoclonal antibodies and their uses

Therapeutic application of Kazal-type serine protease inhibitors

Method for purifying enzymes from clostridium histolyticum using mu...

Patents Applicationslast 30 patents

METHODS OF ADMINISTERING INHIBITORY ANTI-FACTOR XII/XIIA MONOCLONAL...

IMPROVED FACTOR VIII PREPARATIONS SUITABLE FOR THERAPEUTIC USE AND...

INHIBITORY ANTI-FACTOR XII/XIIA MONOCLONAL ANTIBODIES AND THEIR USES

INHIBITORY ANTI-FACTOR XII/XIIA MONOCLONAL ANTIBODIES AND THEIR USES

INHIBITORY ANTI-FACTOR XII/XIIA MONOCLONAL ANTIBODIES AND THEIR USES

THERAPEUTIC APPLICATION OF KAZAL-TYPE SERINE PROTEASE INHIBITORS

Method for purifying an enzyme, a purified enzyme produced thereby,...